What does it mean for covered entities already desparate for diminishing 340B savings and revenue? As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers to evade the discounts they are legally obligated to offer eligible entities — by placing … Read More
340B ESP ‘Terms Of Use’ Set The Tone For The Spurious Demands It Places On Covered Entities.
